HemaSphere
(Jun 2022)
PB1811: BIOLOGIC AND CLINICAL SIGNIFICANCE OF CD7 ABERRANT EXPRESSION IN ACUTE MYELOID LEUKEMIA: A POOR PROGNOSIS MARKER
- H. Charfi,
- N. Louati,
- G. Baccar,
- O. Kassar,
- N. Siala,
- Y. Fakhfakh,
- M. Chaari,
- M. Ellloumi,
- J. Gargouri,
- H. Menif,
- T. Rekik,
- I. Ben amor
Affiliations
- H. Charfi
- 1 hematology, Hedi Chaker Hospital
- N. Louati
- 2 hematology, regional blood transfusion center
- G. Baccar
- 2 hematology, regional blood transfusion center
- O. Kassar
- 1 hematology, Hedi Chaker Hospital
- N. Siala
- 1 hematology, Hedi Chaker Hospital
- Y. Fakhfakh
- 1 hematology, Hedi Chaker Hospital
- M. Chaari
- 3 hematology laboratory, Hedi Chaker Hospital, Sfax, Tunisia
- M. Ellloumi
- 1 hematology, Hedi Chaker Hospital
- J. Gargouri
- 2 hematology, regional blood transfusion center
- H. Menif
- 2 hematology, regional blood transfusion center
- T. Rekik
- 2 hematology, regional blood transfusion center
- I. Ben amor
- 2 hematology, regional blood transfusion center
- DOI
-
https://doi.org/10.1097/01.HS9.0000850096.02871.10
- Journal volume & issue
-
Vol. 6
pp.
1691
– 1692
WeChat QR code